Literature DB >> 15380124

Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.

Edgar Kockelmann1, Christian E Elger, Christoph Helmstaedter.   

Abstract

RATIONALE: This retrospective study was conducted to identify cognitive domains affected by topiramate (TPM), and to evaluate the role of blood serum levels of TPM and comedication in the etiology of TPM-induced cognitive impairment.
METHODS: Forty-two patients on AED polytherapy containing topiramate and a random sample of 42 patients with lamotrigine as the corresponding agent underwent extensive neuropsychological testing. Current blood serum levels of TPM were correlated with test scores.
RESULTS: Patients on TPM scored significantly worse in phonematic verbal fluency, memory spans, and working memory; language and memory function were not affected per se. In few cognitive domains, serum levels of TPM and performance were correlated before correction for multiple testing. Drug load of additional medication did not account for differences between or within groups. DISCUSSION: Consistent with previous reports, patients on AED polytherapy including TPM display a cognitive pattern with specific impairment in executive functions. The severity of the cognitive side effects of TPM may be related to dosing to a certain extent, but this relationship may be disclosed only with larger sample sizes. Accordingly, TPM dosage does not appear to be a good indicator of TPM-related cognitive side effects in the individual patient.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380124     DOI: 10.1016/j.yebeh.2004.06.017

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  14 in total

1.  The cognitive impact of antiepileptic drugs.

Authors:  Clare M Eddy; Hugh E Rickards; Andrea E Cavanna
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

2.  Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals.

Authors:  Bankole A Johnson; John D Roache; Nassima Ait-Daoud; Lynda T Wells; Christopher L Wallace; Michael A Dawes; Lei Liu; Xin-Qun Wang
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-09-15       Impact factor: 5.067

Review 3.  Suicidality and antiepileptic drugs: is there a link?

Authors:  Vladimir V Kalinin
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 4.  Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management.

Authors:  Timothy E Welty
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

5.  The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory.

Authors:  S E Marino; S V S Pakhomov; S Han; K L Anderson; M Ding; L E Eberly; D W Loring; C Hawkins-Taylor; J O Rarick; I E Leppik; J E Cibula; A K Birnbaum
Journal:  Epilepsy Behav       Date:  2012-05-30       Impact factor: 2.937

6.  Severity of Topiramate-Related Working Memory Impairment Is Modulated by Plasma Concentration and Working Memory Capacity.

Authors:  Samuel P Callisto; Sílvia M Illamola; Angela K Birnbaum; Christopher M Barkley; Sai Praneeth R Bathena; Ilo E Leppik; Susan E Marino
Journal:  J Clin Pharmacol       Date:  2020-04-16       Impact factor: 3.126

Review 7.  Review of topiramate for the treatment of epilepsy in elderly patients.

Authors:  B R Sommer; H H Fenn
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

Review 8.  Topiramate: a review of its use in the treatment of epilepsy.

Authors:  Katherine A Lyseng-Williamson; Lily P H Yang
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.

Authors:  Richard P Shank; Bruce E Maryanoff
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

10.  Altered language processing in autosomal dominant partial epilepsy with auditory features.

Authors:  R Ottman; L Rosenberger; A Bagic; K Kamberakis; E K Ritzl; A M Wohlschlager; S Shamim; S Sato; C Liew; W D Gaillard; E Wiggs; M M Berl; P Reeves-Tyer; E H Baker; J A Butman; W H Theodore
Journal:  Neurology       Date:  2008-12-09       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.